A study reveals a U-shaped relationship between BMI and CAR T-cell therapy outcomes in multiple myeloma (MM), highlighting the impact of overweight status on efficacy.
Andrea Eleazar, MHS
Advertisement
Andrea Eleazar, MHS, is an assistant editor for Targeted Oncology, with interests in noncommunicable diseases, health equity research, and global health. Eleazar holds a Master of Health Science in Epidemiology from the Johns Hopkins Bloomberg School of Public Health, as well as a BS in Public Health and certificate in Writing & Publishing from Drexel University.
Articles by Andrea Eleazar, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
2
Long-Term Remission in Ph-Negative B-ALL With Sequential CAR T, ASCT
3
5 Ways ACOs Can Improve Care, Achieve Meaningful Savings
4
TAM Receptors Promising Therapeutic Targets in Rheumatoid Arthritis
5
